Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients

Archives of Gynecology and Obstetrics

Volumn 272, Issue 2, 2005, Pages 136-141

  Wang, Xipeng ^a   Huang, Ziying ^a   Di, Wen ^a   Lin, Qide ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROLIFERATION CELL NUCLEAR ANTIGEN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; CURETTAGE; DISEASE ASSOCIATION; ENDOMETRIAL DISEASE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MYOMETRIUM; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SAMPLING; TUMOR LOCALIZATION;

AGED; DILATATION AND CURETTAGE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 21744453630     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0712-0     Document Type: Article

References (27)

1. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7-33
2. Cowles TA, Magrina JF, Masterson BJ, Capen CV (1985) Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 66:413-416
3. Tiitinen A, Forss M, Aho I, Vesterinen E, Nieminen U (1986) Endometrial adenocarcinoma: clinical outcome in 881 patients and analysis of 146 patients whose deaths were due to endometrial cancer. Gynecol Oncol 25:11-19
4. Epstein E, Skoog L, Valentin L (2001) Comparison of Endorette and dilatation and curettage for sampling of the endometrium in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 80:959-964
5. Isaacson K (2002) Office hysteroscopy: a valuable but under-utilized technique. Curr Opin Obstet Gynecol 14:381-385
6. Del Priore G, Williams R, Harbatkin CB, Wan LS, Mittal K, Yang GC (2001) Endometrial brush biopsy for the diagnosis of endometrial cancer. J Reprod Med 46:439-443
7. Symonds I (2001) Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15:381-391
8. Emanuel MH, Wamsteker K, Lammes FB (1997) Is dilatation and curettage obsolete for diagnosing intrauterine disorders in premenopausal patients with persistent abnormal uterine bleeding? Acta Obstet Gynecol Scand 76:65-68
9. Petersen RW, Quinlivan JA, Casper GR, Nicklin JL (2000) Endometrial adenocarcinoma - presenting pathology is a poor guide to surgical management. Aust N Z J Obstet Gynaecol 40:191-194
10. Oakley G, Nahhas WA (1989) Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue. Eur J Gynaecol Oncol 10:255-260
11. Soothill PW, Alcock CJ, MacKenzie IZ (1989) Discrepancy between curettage and hysterectomy histology in patients with stage 1 uterine malignancy. Br J Obstet Gynaecol 96:478-481
12. Mitchard J, Hirschowitz L (2003) Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens. Histopathology 42:372-378
13. Barakat RR, Gilewski TA, Almadrones L et al (2000) Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 18:3459-3463
14. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP (2000) The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89:1765-1772
15. Vorgias G, Lekka J, Katsoulis M, Varhalama E, Kalinoglou N, Akrivos T (2003) Diagnostic accuracy of prehysterectomy curettage in determining tumor type and grade in patients with endometrial cancer. MedGenMed 5:7
16. Obermair A, Geramou M, Gucer F et al (1999) Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 9:383-386
17. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R (1982) Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Gynecol Oncol 13:373-392
18. Creasman WT, Morrow CP, Bunday BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035-2041
19. Xie X, Lu WG, Ye DF, Chen HZ, Fu YF (2002) The value of curettage in diagnosis of endometrial hyperplasia. Gynecol Oncol 84:135-139
20. Mikuta JJ (1995) Preoperative evaluation and staging of endometrial cancer. Cancer 76 [Suppl 10]:2041-2043
21. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA (1988) The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 72:388-393
22. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
23. Reed JC, Miyashita T, Takayama S et al (1996) BCL2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60:23-32
24. Garzetti GG, Ciavattini A, Goteri G, De Nictolis M, Romanini C (1996) Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients. Gynecol Oncol 61:16-21
25. Penney G, Vale L, Souter V, Templeton A (1997) Endometrial assessment procedures: an audit of current practice in Scotland. Hum Reprod 12:2041-2045
26. Gull B, Karlsson B, Milsom I, Granberg S (2003) Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 188:401-408
27. Patai K, Szentmariay IF, Jakab Z, Szilagyi G (2002) Early detection of endometrial cancer by combined use of vaginal ultrasound and endometrial vacuum sampling. Int J Gynecol Cancer 12:261-264